Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma

被引:0
作者
Masahiro Abe
机构
[1] University of Tokushima Graduate School of Medical Sciences,Department of Medicine and Bioregulatory Sciences
来源
International Journal of Hematology | 2011年 / 94卷
关键词
Osteoclast; Osteoblast; Angiogenesis; Myeloma niche;
D O I
暂无
中图分类号
学科分类号
摘要
Cellular interplay in the bone marrow (BM) microenvironment in multiple myeloma (MM) mediates MM growth and the formation of bone-destructive lesions. MM cells show enhanced osteoclastogenesis, and stimulate angiogenesis in concert with BM stromal cells and osteoclasts, whereas they suppress osteoblastic differentiation, leading to devastating bone destruction and the rapid loss of bone. Importantly, osteoclasts, vascular endothelial cells, and BM stromal cells with defective osteoblastic differentiation create a cellular microenvironment suitable for MM growth and survival and confer a drug resistance to MM cells, which can be construed as the “MM niche”. Therefore, the MM niche must be targeted and disrupted to improve the efficacy of anti-tumor treatment and prevent the progression of bone disease in MM. Clarifying molecular mechanisms leading to the formation of the MM niche along with bone disease will help in the development of novel approaches targeting the interplay between MM cells and the BM microenvironment.
引用
收藏
页码:334 / 343
页数:9
相关论文
共 573 条
  • [1] Abildgaard N(2003)Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy Br J Haematol 120 235-242
  • [2] Brixen K(2000)Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients Br J Haematol 109 24-29
  • [3] Kristensen JE(2003)Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index Blood 102 1064-1069
  • [4] Eriksen EF(1998)Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts Biochem Biophys Res Commun 242 703-709
  • [5] Nielsen JL(1998)RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis Biochem Biophys Res Commun 253 395-400
  • [6] Heickendorff L(1999)Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand Proc Natl Acad Sci USA 96 3540-3545
  • [7] Fonseca R(2000)RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism Proc Natl Acad Sci USA 97 1566-1571
  • [8] Trendle MC(2006)RANKL-RANK signaling in osteoclastogenesis and bone disease Trends Mol Med 12 17-25
  • [9] Leong T(2001)Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression Proc Natl Acad Sci USA 98 11581-11586
  • [10] Kyle RA(2006)Multiple myeloma bone disease: pathophysiology of osteoblast inhibition Blood 108 3992-3996